Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study.

David LangWolfgang HaslingerKaveh AkbariMario ScalaBenedikt HerganChristian AselAndreas HornerRomana WassElmar BrehmBernhard KaiserBernd Lamprecht

Published in: Lung Cancer (Auckland, N.Z.) (2020)

Leading STM dynamics provide predictive biomarker information additional to radiological response evaluation patients receiving CHT-ICI combination therapy, especially in the mono-ICI maintenance setting.

Keyphrases

combination therapy
small cell lung cancer
healthcare
health information
squamous cell carcinoma
radiation therapy
brain metastases
drug delivery
tyrosine kinase